G-DS-75 (Diclofenac Sodium Delayed Release 75 mg)
Pill with imprint G-DS-75 is Pink, Round and has been identified as Diclofenac Sodium Delayed Release 75 mg. It is supplied by UDL Laboratories Inc.
Diclofenac is used in the treatment of back pain; ankylosing spondylitis; frozen shoulder; aseptic necrosis; spondyloarthritis and belongs to the drug class Nonsteroidal anti-inflammatory drugs. There is positive evidence of human fetal risk during pregnancy. Diclofenac 75 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for G-DS-75

Diclofenac Sodium Delayed Release
- Imprint
- G-DS-75
- Strength
- 75 mg
- Color
- Pink
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Nonsteroidal anti-inflammatory drugs
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- UDL Laboratories Inc
- Inactive Ingredients
-
FD&C Red No. 40,
FD&C Yellow No. 6,
lactose monohydrate,
magnesium stearate,
methacrylic acid,
microcrystalline cellulose,
dimethicone,
silicon dioxide,
sodium hydroxide,
magnesium silicate,
titanium dioxide,
ferrosoferric oxide,
ammonia,
shellac,
propylene glycol
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
51079-0224 (Discontinued) | UDL Laboratories Inc. |
00378-6281 (Discontinued) | Mylan Pharmaceuticals Inc. |
More about diclofenac
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (655)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: Nonsteroidal anti-inflammatory drugs
- Latest FDA Alerts (11)
Patient resources
- Drug Information
- Diclofenac (Advanced Reading)
- Diclofenac Intravenous (Advanced Reading)
- Diclofenac Capsules
- Diclofenac Delayed-Release Tablets
- Other brands
- Voltaren, Cataflam, Cambia, Zorvolex, ... +3 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.